Disease | breast cancer |
Phenotype | C0002871|anemia |
Sentences | 9 |
PubMedID- 20798194 | Early intervention with epoetin alfa was well tolerated and improved anemia-related pros in patients with breast cancer receiving myelotoxic chemotherapy. |
PubMedID- 24554413 | Erythropoietin-stimulating agents (esas) are used in breast cancer patients with chemotherapy-induced anemia to alleviate anemia and in turn, reduce fatigue. |
PubMedID- 20361359 | Use of anthracyclines, taxanes or platinums was associated with increased risks of short- (=3 months) and long-term (>3 months) anemia and neutropenia in patients with breast cancer. |
PubMedID- 25248898 | [metastatic breast cancer with microangiopathic hemolytic anemia successfully treated by using eribulin]. |
PubMedID- 22123411 | Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy. |
PubMedID- 26102512 | Patients had to be 65 years of age or older at the start of at least 1 year of continuous enrollment and to have lung and/or breast cancers along with chemotherapy-induced anemia (cia) in both pre-rems and post-rems periods (1q2008 through 4q2009 and 1q2010 through 4q2011, respectively). |
PubMedID- 26370220 | Sotatercept (ace-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies. |
PubMedID- 26291454 | Our study added to evidence with respect to the prognostic value of pretreatment anemia in patients with breast cancer. |
PubMedID- 23254961 | A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine. |
Page: 1